81
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers

, , , , , , & show all
Pages 705-715 | Published online: 19 Jun 2018

References

  • DanielsenKOlsenAOWilsgaardTFurbergASIs the prevalence of psoriasis increasing? A 30-year follow-up of a population-based cohortBr J Dermatol201316861303131023374051
  • WHOGlobal report on psoriasis2016World Health Organization Available from: http://www.who.int/iris/handle/10665/204417Accessed May 1, 2018
  • ChristophersEPsoriasis− epidemiology and clinical spectrumClin Exp Dermatol200126431432011422182
  • ParisiRSymmonsDPGriffithsCEAshcroftDMIdentification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project teamGlobal epidemiology of psoriasis: a systematic review of incidence and prevalenceJ Invest Dermatol2013133237738523014338
  • DuffinKCIdentifying and managing complications and comorbidities in patients with psoriasisPaper presented at: Seminars in Cutaneous Medicine and Surgery2015
  • ShahKMellarsLChangolkarAFeldmanSRReal-world burden of comorbidities in US patients with psoriasisJ Am Acad Dermatol2017772287292.e428623046
  • ThomasJKumarNAManoharanDCynthiaSPrabuSSAhmedNAA study of comorbid conditions in psoriasisJ Pak Assoc Dermatol2016194200202
  • ArmestoSCoto-SeguraPOsunaCCamblorPSantos-JuanesJPsoriasis and hypertension: a case-control studyJ Eur Acad Dermatol Venereol201226678578821569114
  • CohenADWeitzmanDDreiherJPsoriasis and hypertension: a case-control studyActa Derm Venereol2010901232620107721
  • GottliebABDannFComorbidities in patients with psoriasisAm J Med2009122121150.e1e9
  • NiCChiuMWPsoriasis and comorbidities: links and risksClin Cosmet Investig Dermatol20147119132
  • YeungHTakeshitaJMehtaNNPsoriasis severity and the prevalence of major medical comorbidity: a population-based studyJAMA Dermatol2013149101173117923925466
  • MehtaNNYuYPinnelasRAttributable risk estimate of severe psoriasis on major cardiovascular eventsAm J Med20111248775.e1e621787906
  • ArmstrongAWHarskampCTArmstrongEJThe association between psoriasis and hypertension: a systematic review and meta-analysis of observational studiesJ Hypertens201331343344323249828
  • NeimannALShinDBWangXMargolisDJTroxelABGelfandJMPrevalence of cardiovascular risk factors in patients with psoriasisJ Am Acad Dermatol200655582983517052489
  • LudvigssonJFAnderssonEEkbomAExternal review and validation of the Swedish national inpatient registerBMC Public Health201111145021658213
  • WettermarkBHammarNForedCMThe new Swedish prescribed drug register-opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiol Drug Saf200716772673516897791
  • WHOWHO collaborating center for Drug Statistics Methodology2016 Available from: https://www.whocc.no/atc_ddd_indexAccessed June 26, 2016
  • LudvigssonJFAlmqvistCBonamyAKRegisters of the Swedish total population and their use in medical researchEur J Epidemiol201631212513626769609
  • EgebergAGyldenloveMZachariaeCSkovLValidation of psoriasis severity classification based on use of topical or systemic treatmentJ Eur Acad Dermatol Venereol2018321e4e528646609
  • LoftNSkovLBryldLEGislasonGEgebergATreatment history of patients receiving biologic therapy for psoriasis – a Danish nationwide studyJ Eur Acad Dermatol Venereol2017318e362e36328168750
  • NorlinJMSteen CarlssonKPerssonUSchmitt-EgenolfMResource use in patients with psoriasis after the introduction of biologics in SwedenActa Derm Venereol201595215616124819980
  • Al-MutairiNAl-FaragSAl-MutairiAAl-ShiltawyMComorbidities associated with psoriasis: an experience from the Middle EastJ Dermatol201037214615520175849
  • LindbladUEkJEcknerJLarssonCAShanGRåstamLPrevalence, awareness, treatment, and control of hypertension: rule of thirds in the Skaraborg projectScand J Prim Health Care2012302889422643153
  • HammarNAlfredssonLRosenMSpetzCLKahanTYsbergASA national record linkage to study acute myocardial infarction incidence and case fatality in SwedenInt J Epidemiol200130Suppl 1S30S3411759848
  • MalkiNKoupilIElorantaSTemporal trends in incidence of myocardial infarction and ischemic stroke by socioeconomic position in Sweden 1987–2010PLoS One201498e10527925170919
  • CarlssonACWändellPÖsbyUZarrinkoubRWettermarkBLjunggrenGHigh prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden–a challenge for public healthBMC Public Health201313167023866784
  • AnderssonTAhlbomACarlssonSDiabetes prevalence in Sweden at present and projections for year 2050PLoS One20151011e014308426619340
  • RahmanPSchentagCTGladmanDDImmunogenetic profile of patients with psoriatic arthritis varies according to the age at onset of psoriasisArthritis Rheum199942481882310211900
  • SmithAEKassabJYRowland PayneCMBeerWEBimodality in age of onset of psoriasis, in both patients and their relativesDermatology199318631811868453143
  • FerrándizCPujolRMGarcía-PatosVBordasXSmandíaJAPsoriasis of early and late onset: a clinical and epidemiologic study from SpainJ Am Acad Dermatol200246686787312063483
  • KwonHHKwonIHYounJIClinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype?Int J Dermatol2012511535822182378
  • MelskiJWSternRSThe separation of susceptibility to psoriasis from age at onsetJ Invest Dermatol19817764744777310171
  • LangleyRGKruegerGGGriffithsCEPsoriasis: epidemiology, clinical features, and quality of lifeAnn Rheum Dis200564Suppl 2ii18ii2315708928